Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
The University of Paris Selects ACD/Percepta Software to Enhance Teaching and Research into Pharmaceuticals
Monday, December 16, 2013
ADME/Tox and PhysChem predictions on the Percepta Platform will help educate and train the next generation of pharmaceutical scientists.

TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.

Molecular Devices Announces Next-Generation SpectraMax MiniMax 300 Imaging Cytometer
Tuesday, December 03, 2013
Sensitive, flexible, field-upgradeable system supports a wide range of applications.

New Fiber Optic Pressure Sensing Systems for Life Science Researchers
Monday, November 11, 2013
New FISO-LS system designed for multi-use, non-disposable applications.

Almac Launches New [14C]-labelled ADCs Service Offering
Monday, November 11, 2013
Antibody drug conjugates for the treatment of various cancer types.

NETZSCH Unveils the New Paradigm in Differential Scanning Calorimetry
Thursday, November 07, 2013
For the first time, each of the steps involved in running a Differential Scanning Calorimetry (DSC) measurement has been taken into account in developing a comprehensive new solution.

Agilent Offers Dissolution Sampling Solution for Enhanced Laboratory Workflow
Tuesday, November 05, 2013
Agilent Technologies Inc. introduce the 850-DS Dissolution Sampling Station for centralizing laboratory workflow of sample transfer, filtration and collection.

Merck Millipore Introduces Parteck® SLC
Wednesday, October 23, 2013
Delivers dramatically increased solubility and bioavailability.

Astech Projects to Exhibit at P-Mec - CPhi Worldwide
Monday, October 21, 2013
Astech Projects will be exhibiting their latest pharmaceutical technology services within the P-MEC product zone of the world’s leading pharmaceutical networking event, CPhi Worldwide, 22 - 24 October 2013, Messe Frankfurt Germany.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 668
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters